We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PTIX market cap is 3.6M. The company's latest EPS is USD -0.7359 and P/E is -0.75.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.43M | -1.21M | -1.74M | -1.67M | -652k |
Net Income | -1.4M | -1.68M | -1.72M | -1.61M | -641k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.09M | -2.55M | -4.14M | -3.56M | -4.53M |
Net Income | -1.75M | -2.55M | -4.52M | -3.56M | -5M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.43M | 4.32M | 2.58M | 1.47M | 1.51M |
Total Liabilities | 1.28M | 655k | 447k | 674k | 789k |
Total Equity | 4.15M | 3.67M | 2.13M | 793k | 719k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 842k | 879k | 11.06M | 8.04M | 4.32M |
Total Liabilities | 1.48M | 2.03M | 1.12M | 1.12M | 655k |
Total Equity | -634k | -1.15M | 9.94M | 6.92M | 3.67M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.56M | -3.7M | -1.66M | -3.21M | -3.4M |
Investing | 2.5M | 4.78M | 1.2M | 2.8M | 2.8M |
Financing | N/A | N/A | N/A | 45k | 361k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -488k | -1.35M | -2.8M | -1.99M | -3.7M |
Investing | 250k | N/A | -9.91M | 1.6M | 4.78M |
Financing | 670k | 1.22M | 12.58M | N/A | N/A |
Market Cap | 3.6M |
Price to Earnings Ratio | -0.75 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.9 |
Price to Book Ratio | 1.02 |
Dividend Yield | - |
Shares Outstanding | 6.79M |
Average Volume (1 week) | 123.28k |
Average Volume (1 Month) | 448.3k |
52 Week Change | -36.67% |
52 Week High | 1.87 |
52 Week Low | 0.4515 |
Spread (Intraday) | 0.03 (5.36%) |
Company Name | Protagenic Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.protagenic.com |
Industry | books: pubg, pubg & printing (2731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions